Pharmacy Benefit Managers Begin to Cut Ties With Specialty Pharmacies

Conclusion As these cases continue to wind their way through the courts, it is unknown if they will be joined by others. However, what is known is that all pharmacies can likely expect greater oversight after the disclosures of Valeant and Philidor.       Related StoriesMedicare Releases Drug Data to the Public: Medicare Drug Spending Dashboard 2014Health and Human Services Drug Pricing ForumSenators McCain and Grassley Request HHS for Approval of Importation of Certain Drugs 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs